Leukemia

LEUKEMIA NEWS TIPS & FEATURES

Venclexta® and Low-doses of Cytarabine Effective in Elderly with Acute Myeloid Leukemia

January 26th, 2017

Venclexta® and Low-doses of Cytarabine Effective in Elderly with Acute Myeloid Leukemia

The treatment combination consisting of Venclexta® (venetoclax) plus low-doses of the chemotherapy agent cytarabine appears to be an effective and tolerable treatment regimen for elderly […]


Roswell Park Researchers Offer Novel Insight into Genetic Changes Leading to Cancer

January 18th, 2017

Roswell Park Researchers Offer Novel Insight into Genetic Changes Leading to Cancer

Findings may lead to personalized prognostic tests for blood disorders Predisposition to cancer and cancer progression can result from gene mutations that cause elevated rates […]


Progress Reported in New Treatments for People with Lymphoma

December 29th, 2016

Progress Reported in New Treatments for People with Lymphoma

Research and pharmaceutical executives unveil encouraging clinical trial data at the annual meeting of the American Society of Hematology. Twenty-two years ago, Dr. Gary Gordon, […]


FDA Grants Iclusig® Expanded Approval for CML

December 14th, 2016

FDA Grants Iclusig® Expanded Approval for CML

The United States Food and Drug Administration (FDA) has granted Iclusig® (ponatinib) approval to treat all phases of chronic myeloid leukemia (CML) in adults, as […]


UCLA Identifies Potential Cancer Treatment with Fewer Side Effects Than Chemotherapy

December 12th, 2016

UCLA Identifies Potential Cancer Treatment with Fewer Side Effects Than Chemotherapy

By Stuart Wolpert, UCLA Asynthetic version of a rare toxin produced by a sea creature appears to hold promise for treating many different types of […]


Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

December 1st, 2016

Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring […]


Useful Definitions for Chronic Myelogenous Leukemia (CML)

November 16th, 2016

Useful Definitions for Chronic Myelogenous Leukemia (CML)

Blood stem cell: An immature cell from which other types of blood cells develop. Bone marrow: The soft, sponge-like tissue in the center of most […]


FDA Priority Review Granted for Midostaurin in Leukemia

November 15th, 2016

FDA Priority Review Granted for Midostaurin in Leukemia

The United States Food and Drug Administration (FDA) has granted priority review to PKC412 (midostaurin) in the treatment of newly diagnosed acute myeloid leukemia (AML) […]


Discovery of Ezh2 May Represent New Treatment Option for Chronic Myelogenous Leukemia

November 3rd, 2016

Discovery of Ezh2 May Represent New Treatment Option for Chronic Myelogenous Leukemia

Each year in the United States, approximately 5,000 people are diagnosed with CML. Most cases of CML are characterized by a chromosomal abnormality—the Philadelphia chromosome—in […]


LLS Launches Groundbreaking Precision Medicine Approach To Treat AML

November 1st, 2016

LLS Launches Groundbreaking Precision Medicine Approach To Treat AML

Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) announced the launch of a groundbreaking, […]


More News →